Table 2

Clinical and demographic characteristics and unadjusted outcomes

CeAD and IAT (n=24)CeAD, No IAT (n=137)CeAD, IVT alone (n=11)Non-CeAD mechanism (n=421)
Age (years)52 (43–60)44 (35–54)†52 (37–59)70 (61–79)‡
Female sex25.0 (6)41.6 (57)*36.4 (4)54.16 (228)‡
White race83.3 (20)65.0 (89)100.0 (11)77.4 (326)
Transferred in83.3 (20)69.3 (95)72.7 (8)71.7 (302)
IV tPA45.8 (11)8.0 (11)‡100 (11)58.4 (246)
Initial NIHSS13 (12–16)3 (1–7)‡10 (7–12)†18 (13–22)†
Discharge NIHSS6 (3–13)1 (0–3)‡9 (3–16.5)1 (0–3)‡
Change in NIHSS−9 (−11–1)1 (−3–0)†−4 (−5.5–5)−10 (−15–5)
Discharge mRS4 (3–4)2 (1–3)3.5 (3–4)2 (1–3)‡
90 day mRS 0–2§65.0 (13/20)93.0 (93)‡60.0 (3/5)53.7 (145/270)
Symptomatic ICH4.0 (1/25)0 (0)*0.0 (0/11)6.4 (27/421)
Inhospital mortality16.0 (4/25)3.7 (5)†9.1 (1/11)16.4 (69/421)
  • Values are % (n) or median (IQR).

  • Change in NIHSS: discharge NIHSS—initial NIHSS (negative values indicate improvement).

  • Pearson χ2 p value versus CeAD and IAT. *<0.15. †<0.05. ‡<0.01. §Defined as mRS 0–2 at 90 days or discharge, or discharge home.

  • CeAD, cervical artery dissection; IAT, intra-arterial thrombolysis; ICH, intracerebral hemorrhage; IVT, intravenous thrombolysis; IV tPA, intravenous tissue plasminogen activator; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.